(lp0
S"Can PDL BioPharma, Inc. Turn Things Around? Motley Fool - Oct 28, 2016 In 18 months, PDL BioPharma, Inc.  has lost roughly half of its market cap. The slide wasn't unexpected: Investors have known for a long time that PDL BioPharma's core patents would expire at the end of 2014."
p1
aS"Better Buy: PDL BioPharma, Inc. vs. Johnson &amp; Johnson Motley Fool - Feb 27, 2017 Biotech finance specialist PDL Biopharma  has been suffering a prolonged market thrashing that's driven its stock price down about 75% over the past three years.Stock Returns: Cytokinetics, Incorporated  versus PDL BioPharma ... - CML NewsPDL BioPharma, Inc.  shows monthly volitility of 3.49% - The Newburgh Press"
p2
aS"Why PDL BioPharma Inc. Is Down 14.8% Today Motley Fool - Nov 23, 2016 Shares in PDL BioPharma  are tumbling 14.8% at 12:30 p.m. EST Wednesday after management closed on a $150 million convertible notes offering and Eli Lilly &amp; Co.Company Update : Here's Why PDL BioPharma Inc Shares Are Slumping ... - Smarter Analyst"
p3
aS"Here's Why PDL BioPharma Inc. Imploded and Fell 32% in November Motley Fool - Dec 2, 2016 Shares of PDL BioPharma , a biotech royalty company, imploded in November and lost 32% of their value according to data from S&amp;P Global Market Intelligence."
p4
aS'PDL BioPharma Inc.  Moves Higher on Volume Spike for March 17 Equities.com - Mar 17, 2017 PDL BioPharma Inc.  traded on unusually high volume on Mar. 17, as the stock gained 1.38% to close at $2.21. On the day, PDL BioPharma Inc. saw 2.83 million shares trade hands on 9,267 trades. Considering that the stock averages only a daily&nbsp;...The PDL BioPharma Inc  Position Held by Barings LLC - Petro Global News 24Right time to invest?  PDL BioPharma, Inc. , Pulmatrix, Inc.  - USA Commerce Daily'
p5
aS'PDL BioPharma to Present at Two Upcoming Investor Conferences PR Newswire  - Mar 2, 2017 PDL has committed over $1.4 billion and funded approximately $1.1 billion in these investments to date. PDL is headquartered in Incline Village, Nevada.PDL BioPharma Inc.: PDL BioPharma to Present at Two Upcoming Investor Conferences - The Wall Street TranscriptPDL BioPharma reports 4Q loss - Yahoo Finance'
p6
aS'This Expected News Sent PDL BioPharma Inc. Down 17% in August Motley Fool - Sep 7, 2016 Shares of PDL BioPharma , a royalty company in the biotech space that earns its keep by reaping the rewards of its acquired intellectual property and low overhead costs, sank 17% in August, according to data from S&amp;P Global Market&nbsp;...'
p7
aS'PDL BioPharma: 2017 Could Be A Game-Changer Seeking Alpha - Mar 3, 2017 PDLI is a unique company in the biotech world. Traditionally, their business revolved primarily around purchasing income generating assets in the biotech sector, such as patents or providing debt structures for biotech firms at high interest rates.'
p8
aS'PDL BioPharma Announces Proposed $150 Million Public Offering of New ... PR Newswire  - Nov 15, 2016 15, 2016 /PRNewswire/ -- PDL BioPharma, Inc.   announced today that it intends to offer, subject to market and other conditions, $150 million aggregate principal amount of new convertible senior notes due December 1, 2021 (the&nbsp;...'
p9
aS"PDL BioPharma Prices Public Offering of $150.0 Million of 2.75% Convertible ... PR Newswire  - Nov 17, 2016 INCLINE VILLAGE, Nev., Nov. 17, 2016 /PRNewswire/ -- PDL BioPharma, Inc.   announced today that it has agreed to sell $150.0 million aggregate principal amount of its 2.75% Convertible Senior Notes due 2021  in an&nbsp;...Why Lowe's Companies, Inc. , PDL BioPharma Inc  and Mallinckrodt ... - Investorplace.com"
p10
a.